In my previous post, I calculated something wrong enough which I thought need to be re-entered, so I self reported.
Back in March 2023 this webinar slide shows anticipated with willingness to use in approx 35% of the 2L patients
So of the 3.7M people currently seeking treatment for AHH, if they are willing to be tried at 1L or 2L, aiming for 35% seems high, but certainly very welcome if it comes to pass. 5 to 10% would be game changing
Full slide shown for reference below
In my previous post, I calculated something wrong enough which I...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |